Insights that
shape the domain
Deep-dive into expert opinions, scientific perspectives, and thought leadership shaping the future of cancer care.
28 August 2022
Revolutionary Blood Test Detects Cancer Relapse Early | Dr. Jayant Khandare
Discover India's first approved, highly affordable blood test that detects cancer relapse and metastasis earlier than traditional CT or MRI scans. Developed by Dr. Jayant Khandare and clinically validated with Tata Memorial Hospital, this painless test catches circulating tumor cells before it's too late.
9 August 2022
Preventing Stage 4 Cancer: India’s Revolutionary Blood Test | Dr. Nirmal Raut
Leading oncologists discuss OncoDiscover, India's first indigenous CTC blood test. By detecting Circulating Tumor Cells post-treatment, this affordable "Made in India" innovation catches cancer relapse before it reaches incurable Stage 4, dramatically changing the landscape of cancer care.
9 August 2022
Made in India: The Low-Cost Blood Test Revolutionizing Cancer Care | Dr. Pankaj Chaturvedi
Dr. Pankaj Chaturvedi (Director, ACTREC) and Dr. Jayant Khandare discuss OncoDiscover, India's first indigenous CTC blood test. By detecting cancer relapse earlier than traditional scans, this groundbreaking "Made in India" technology drastically lowers patient costs and paves the way for future medical innovations.
- Page 1





